Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

14.97
+0.38002.60%
Post-market: 14.970.00000.00%16:10 EST
Volume:598.00K
Turnover:9.01M
Market Cap:757.83M
PE:-4.32
High:15.41
Open:14.74
Low:14.61
Close:14.59
52wk High:15.41
52wk Low:5.04
Shares:50.62M
Float Shares:41.42M
Volume Ratio:0.69
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4644
EPS(LYR):-4.5871
ROE:-76.88%
ROA:-18.54%
PB:4.69
PE(LYR):-3.26

Loading ...

Dec 09, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities